Agilent Announces Collaboration with APC on Real-Time Process Monitoring
27 Maio 2022 - 09:00AM
Business Wire
Agilent Technologies Inc. (NYSE: A) today announced a
collaboration agreement with APC Ltd., in which the companies
commit to working towards combining their technologies to provide
unique workflows to customers that support automated process
analysis via liquid chromatography (LC).
Agilent has selected to partner with APC, a provider of
innovative small molecule and large molecule process design and
process development solutions. Both APC and Agilent pursue similar
goals, which are focused on helping customers in the
biopharmaceutical and pharmaceutical industry to improve the human
condition and to delivering life-changing drugs to market faster
and more efficiently. The collaboration between the companies
leverages their complementary strengths to develop specific
workflows, which bridge the gap between the analytical and process
solutions.
“We are delighted to be collaborating with APC on a solution for
real-time/automated process monitoring,” said Stefan Schuette, vice
president and general manager of Agilent’s Liquid Phase Separations
Division. He added, “Adapting our analytical capabilities to
support online process monitoring requirements reflects the current
trend within the pharma and biopharma industry towards continuous
manufacturing and helps our mutual customers to develop higher
quality drugs faster.”
“Agilent is a leader in the analytical lab with a comprehensive
portfolio of analytical equipment for the biopharma and pharma
industry,” said Damian Connolly, Analytical Lead at APC. “This
collaboration leverages our complementary strengths and ultimately
provides even better services and technologies to our customers by
giving them greater insights into, and control of, their
processes.”
The results obtained during the collaboration will be shared
with customers via applications notes and joint webinars, which
will also showcase the recently launched InfinityLab Online LC and
InfinityLab Bio LC portfolio from Agilent. These new product
offerings and the collaboration with APC ensure a leading position
in the trend towards continuous manufacturing, process analytical
technology (PAT), and real-time release testing (RTRT) in the
biopharmaceutical and pharmaceutical industry.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the
life sciences, diagnostics, and applied chemical markets,
delivering insight and innovation that advance the quality of life.
Agilent’s full range of solutions includes instruments, software,
services, and expertise that provide trusted answers to our
customers' most challenging questions. The company generated
revenue of $6.32 billion in fiscal 2021 and employs 17,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn,
Twitter, and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220527005054/en/
Catherine Kaye Agilent Technologies 07775 410632
Catherine.kaye@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Fev 2024 até Mar 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mar 2023 até Mar 2024